{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:38Z","timestamp":1787020178149,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12879-017-2842-6","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T08:16:05Z","timestamp":1511943365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection\u00a0"],"prefix":"10.1186","volume":"17","author":[{"given":"Yu-Jui","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mel S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hsiang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-8333","authenticated-orcid":false,"given":"Feng-Chih","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,29]]},"reference":[{"issue":"6","key":"2842_CR1","first-page":"443","volume":"61","author":"MA Cataldo","year":"2010","unstructured":"Cataldo MA, Petrosillo N, Cipriani M, Cauda R, Tacconelli E. Prosthetic joint infection: recent developments in diagnosis and management. J Inf Secur. 2010;61(6):443\u20138.","journal-title":"J Inf Secur"},{"issue":"Suppl 2","key":"2842_CR2","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1086\/321863","volume":"33","author":"AF Widmer","year":"2001","unstructured":"Widmer AF. New developments in diagnosis and treatment of infection in orthopedic implants. Clin Infect Dis. 2001;33(Suppl 2):S94\u2013106.","journal-title":"Clin Infect Dis"},{"key":"2842_CR3","first-page":"251","volume":"306","author":"M Otto","year":"2006","unstructured":"Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol. 2006;306:251\u20138.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"7","key":"2842_CR4","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s11999-009-0857-z","volume":"467","author":"J Parvizi","year":"2009","unstructured":"Parvizi J, Azzam K, Ghanem E, Austin MS, Rothman RH. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin Orthop Relat Res. 2009;467(7):1732\u20139.","journal-title":"Clin Orthop Relat Res"},{"issue":"Suppl 1","key":"2842_CR5","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.2106\/00004623-200300001-00014","volume":"85-A","author":"DT Tsukayama","year":"2003","unstructured":"Tsukayama DT, Goldberg VM, Kyle R. Diagnosis and management of infection after total knee arthroplasty. J Bone Joint Surg Am. 2003;85-A(Suppl 1):S75\u201380.","journal-title":"J Bone Joint Surg Am"},{"issue":"1","key":"2842_CR6","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11999-015-4443-2","volume":"474","author":"P Lichstein","year":"2016","unstructured":"Lichstein P, Su S, Hedlund H, Suh G, Maloney WJ, Goodman SB, Huddleston JI 3rd. Treatment of Periprosthetic knee infection with a two-stage protocol using static spacers. Clin Orthop Relat Res. 2016;474(1):120\u20135.","journal-title":"Clin Orthop Relat Res"},{"key":"2842_CR7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00003086-200508000-00003","volume":"437","author":"JW Costerton","year":"2005","unstructured":"Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7\u201311.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"2842_CR8","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.idc.2005.07.010","volume":"19","author":"IG Sia","year":"2005","unstructured":"Sia IG, Berbari EF, Karchmer AW. Prosthetic joint infections. Infect Dis Clin N Am. 2005;19(4):885\u2013914.","journal-title":"Infect Dis Clin N Am"},{"key":"2842_CR9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/BLO.0b013e3181123d4e","volume":"461","author":"CD Salgado","year":"2007","unstructured":"Salgado CD, Dash S, Cantey JR, Marculescu CE. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin Orthop Relat Res. 2007;461:48\u201353.","journal-title":"Clin Orthop Relat Res"},{"issue":"9","key":"2842_CR10","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K. Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008;52(9):3315\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"2842_CR11","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","volume":"30","author":"PC Appelbaum","year":"2007","unstructured":"Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2007;30(5):398\u2013408.","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"2842_CR12","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.00247-06","volume":"50","author":"M Benvenuto","year":"2006","unstructured":"Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50(10):3245\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"2842_CR13","doi-asserted-by":"crossref","unstructured":"Tasse J, Croisier D, Badel-Berchoux S, Chavanet P, Bernardi T, Provot C, Laurent F. Preliminary results of a new antibiotic susceptibility test against biofilm installation in device-associated infections: the Antibiofilmogram(R). Pathog Dis. 2016;74(6)","DOI":"10.1093\/femspd\/ftw057"},{"issue":"6","key":"2842_CR14","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/jac\/dkq109","volume":"65","author":"F Traunm\u00fcller","year":"2010","unstructured":"Traunm\u00fcller F, Schintler MV, Metzler J, Spendel S, Mauric O, Popovic M, Konz KH, Scharnagl E, Joukhadar C. Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010;65(6):1252\u20137.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"2842_CR15","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/phar.1413","volume":"34","author":"R Kullar","year":"2014","unstructured":"Kullar R, McClellan I, Geriak M, Sakoulas G. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Pharmacotherapy. 2014;34(6):582\u20139.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"2842_CR16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/jac\/dks119","volume":"67","author":"PS Corona P\u00e9rez-Cardona","year":"2012","unstructured":"Corona P\u00e9rez-Cardona PS, Barro Ojeda V, Rodriguez Pardo D, Pigrau Serrallach C, Guerra Farf\u00e1n E, Amat Mateu C, Flores SX. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections. J Antimicrob Chemother. 2012;67(7):1749\u201354.","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"2842_CR17","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/AAC.00038-12","volume":"56","author":"I Byren","year":"2012","unstructured":"Byren I, Rege S, Campanaro E, Yankelev S, Anastasiou D, Kuropatkin G, Evans R. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty. Antimicrob Agents Chemother. 2012;56(11):5626\u201332.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2 Suppl 1","key":"2842_CR18","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"2842_CR19","first-page":"48","volume":"16","author":"FC Kuo","year":"2016","unstructured":"Kuo FC, Yen SH, Peng KT, Wang JW, Lee MS. Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin. BMC Infect Dis. 2016;16:48.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2842_CR20","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cis803","volume":"56","author":"DR Osmon","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR. Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1\u201325.","journal-title":"Clin Infect Dis"},{"key":"2842_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.blo.0000224021.73163.61","volume":"451","author":"N Rao","year":"2006","unstructured":"Rao N, Regalla DM. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series. Clin Orthop Relat Res. 2006;451:34\u20137.","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"2842_CR22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/jac\/dkq528","volume":"66","author":"A Gonzalez-Ruiz","year":"2011","unstructured":"Gonzalez-Ruiz A, Beiras-Fernandez A, Lehmkuhl H, Seaton RA, Loeffler J, Chaves RL. Clinical experience with daptomycin in Europe: the first 2.5 years. J Antimicrob Chemother. 2011;66(4):912\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"2842_CR23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ijid.2014.09.012","volume":"29","author":"V Prendki","year":"2014","unstructured":"Prendki V, Zeller V, Passeron D, Desplaces N, Mamoudy P, Stirnemann J, Marmor S, Ziza JM. Outcome of patients over 80 years of age on prolonged suppressive antibiotic therapy for at least 6 months for prosthetic joint infection. Int J Infect Dis. 2014;29:184\u20139.","journal-title":"Int J Infect Dis"},{"issue":"6","key":"2842_CR24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2106\/00004623-200706000-00010","volume":"89","author":"Y Mittal","year":"2007","unstructured":"Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J Bone Joint Surg Am. 2007;89(6):1227\u201331.","journal-title":"J Bone Joint Surg Am"},{"issue":"5","key":"2842_CR25","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/MAJ.0b013e318268023d","volume":"345","author":"B Panwar","year":"2013","unstructured":"Panwar B, Johnson VA, Patel M, Balkovetz DF. Risk of vancomycin-induced nephrotoxicity in the population with chronic kidney disease. Am J Med Sci. 2013;345(5):396\u20139.","journal-title":"Am J Med Sci"},{"issue":"1","key":"2842_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13104-016-2252-7","volume":"9","author":"S Tongsai","year":"2016","unstructured":"Tongsai S, Koomanachai P. The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis. BMC Res Notes. 2016;9(1):455.","journal-title":"BMC Res Notes"},{"issue":"1","key":"2842_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11999-016-4890-4","volume":"475","author":"JM Frank","year":"2017","unstructured":"Frank JM, Kayupov E, Moric M, Segreti J, Hansen E, Hartman C, et al. The mark Coventry, MD, award: oral antibiotics reduce reinfection after two-stage exchange: a multicenter, randomized controlled trial. Clin Orthop Relat Res. 2017;475(1):56\u201361.","journal-title":"Clin Orthop Relat Res"},{"key":"2842_CR28","doi-asserted-by":"crossref","unstructured":"Antony S, Tiscareno-Grajeda I, Misenhiemer G, Heyderman J. Use of Daptomycin in the treatment of prosthetic joint infections a prospective observational study of 30 patients with infected prosthetic joint infections. The internet J Infect Dis. 2009;7(1)","DOI":"10.5580\/1479"},{"issue":"3","key":"2842_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/01.idc.0000206490.05422.df","volume":"14","author":"SJ Antony","year":"2006","unstructured":"Antony SJ, Angelos E, Stratton CW. Clinical experience with Daptomycin in patients with orthopedic-related infections. Infect Dis Clin Pract. 2006;14(3):144\u20139.","journal-title":"Infect Dis Clin Pract"},{"issue":"1","key":"2842_CR30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.diagmicrobio.2014.05.022","volume":"80","author":"J Lora-Tamayo","year":"2014","unstructured":"Lora-Tamayo J, Parra-Ruiz J, Rodr\u00edguez-Pardo D, Barber\u00e1n J, Ribera A, Tornero E, et al. High doses of daptomycin (10 mg\/kg\/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: a comparative study. Diagn Microbiol Infect Dis. 2014;80(1):66\u201371.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"6","key":"2842_CR31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1592\/phco.31.6.527","volume":"31","author":"R Kullar","year":"2011","unstructured":"Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011;31(6):527\u201336.","journal-title":"Pharmacotherapy"},{"key":"2842_CR32","doi-asserted-by":"crossref","unstructured":"Ferrera C, Vilacosta I, Vivas D, Olmos C. Severe daptomycin-induced myopathy. Med Clin (Barc). 2012;139(3):138\u20139.","DOI":"10.1016\/j.medcli.2011.12.001"},{"issue":"3","key":"2842_CR33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1060028013514377","volume":"48","author":"ML Berg","year":"2014","unstructured":"Berg ML, Estes LL, Dierkhising RA, Curran B, Enzler MJ. Evaluation of impact of statin use on development of CPK elevation during daptomycin therapy. Ann Pharmacother. 2014;48(3):320\u20137.","journal-title":"Ann Pharmacother"},{"issue":"3","key":"2842_CR34","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2015.05.008","volume":"46","author":"S Stefani","year":"2015","unstructured":"Stefani S, Campanile F, Santagati M, Mezzatesta ML, Cafiso V, Pacini G. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: a review of the available evidence. Int J Antimicrob Agents. 2015;46(3):278\u201389.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2842_CR35","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s00134-014-3571-6","volume":"41","author":"M Bassetti","year":"2015","unstructured":"Bassetti M, Villa G, Ansaldi F, De Florentiis D, Tascini C, Cojutti P, Righi E, Sartor A, Crapis M, De Rosa FG, Pea F, Menichetti F. Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients. Intensive Care Med. 2015 Feb;41(2):366\u20138.","journal-title":"Intensive Care Med"},{"key":"2842_CR36","doi-asserted-by":"crossref","unstructured":"Moise PA1, North D, Steenbergen JN, Sakoulas G. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis 2009;9(10):617\u2212624.","DOI":"10.1016\/S1473-3099(09)70200-2"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-017-2842-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:56:22Z","timestamp":1603414582000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-017-2842-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,29]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["2842"],"URL":"https:\/\/doi.org\/10.1186\/s12879-017-2842-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,29]]},"article-number":"736"}}